SCHEMBL6490213

SCHEMBL6490213

Cc1cc(COc2cc(C(=O)O)ccn2)cc2c1nc(C)n2Cc1ccc(-c2ccccc2)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.40
ALOX5AP P20292 2/20 0.39
DCTPP1 Q9H773 2/20 0.38
PTGES O14684 1/20 0.38
ALOX5 P09917 1/20 0.38
LTC4S Q16873 1/20 0.38
KDM4C Q9H3R0 7/20 0.37
KDM5A P29375 5/20 0.36
KDM5B Q9UGL1 4/20 0.36
KDM2B Q8NHM5 3/20 0.36
KDM4A O75164 3/20 0.36
PPARG P37231 2/20 0.36
PIK3C2B O00750 2/20 0.35
KDM4E B2RXH2 1/20 0.35
KDM6B O15054 1/20 0.35
KDM4B O94953 1/20 0.35
KDM4D Q6B0I6 1/20 0.35
KDM2A Q9Y2K7 1/20 0.35
KDM3A Q9Y4C1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6489657 0.90 KDM4C (0.42) MRGPRX4ALOX5APDCTPP1KDM4CKDM5A
SCHEMBL6501198 0.88 NR4A2 (0.48) MRGPRX4ALOX5APPPARG
SCHEMBL6502677 0.86 P2RX3 (0.40) MRGPRX4ALOX5APDCTPP1PIK3C2B
SCHEMBL6500955 0.85 KDM4C (0.40) MRGPRX4ALOX5APDCTPP1PTGESALOX5
SCHEMBL6493027 0.84 MCL1 (0.43) MRGPRX4PIK3C2B
SCHEMBL6488551 0.84 PIK3C2B (0.39) PIK3C2B
SCHEMBL6491148 0.83 DCTPP1 (0.45) MRGPRX4ALOX5APDCTPP1PTGESALOX5
SCHEMBL6486764 0.82 DCTPP1 (0.44) ALOX5APDCTPP1PTGESALOX5LTC4S
SCHEMBL6490180 0.81 LMNA (0.41) DCTPP1KDM4CPPARGKDM4E
SCHEMBL6496733 0.81 ALOX5AP (0.47) MRGPRX4ALOX5APDCTPP1PTGESALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD MRGPRX4 2443/4885ALOX5AP 4663/4885DCTPP1 1534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.